ISIN | CH0596284569 |
---|---|
Valor Number | 59628456 |
Bloomberg Global ID | UBPAIUC SW |
Fund Name | UBS (CH) Investment Fund - Equities Switzerland ESG Passive All II U-X-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 |
Asset Class | Bonds |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Das Anlageziel dieses Teilvermögens besteht hauptsächlich darin, den repräsentativen Referenzindex SPI® ESG (TR) für den schweizerischen Aktienmarkt (Bench-mark) passiv nachzubilden und eine Performance zu erzielen, welche dessen Entwicklung entspricht. |
Peculiarities |
Current Price * | 115,456.74 CHF | 16.01.2025 |
---|---|---|
Previous Price * | 114,110.87 CHF | 15.01.2025 |
52 Week High * | 119,979.35 CHF | 02.09.2024 |
52 Week Low * | 105,713.44 CHF | 09.02.2024 |
NAV * | 115,456.74 CHF | 16.01.2025 |
Issue Price * | 115,456.74 CHF | 16.01.2025 |
Redemption Price * | 115,456.74 CHF | 16.01.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 2,177,584,120 | |
Unit/Share Assets *** | 403,638,569 | |
Trading Information SIX |
YTD Performance | +2.83% |
31.12.2024 - 16.01.2025
31.12.2024 16.01.2025 |
---|---|---|
1 month | +2.11% |
16.12.2024 - 16.01.2025
16.12.2024 16.01.2025 |
3 months | -1.98% |
16.10.2024 - 16.01.2025
16.10.2024 16.01.2025 |
6 months | -2.47% |
16.07.2024 - 16.01.2025
16.07.2024 16.01.2025 |
1 year | +8.39% |
16.01.2024 - 16.01.2025
16.01.2024 16.01.2025 |
2 years | +8.60% |
16.01.2023 - 16.01.2025
16.01.2023 16.01.2025 |
3 years | +0.31% |
17.01.2022 - 16.01.2025
17.01.2022 16.01.2025 |
5 years | +19.77% |
11.02.2021 - 16.01.2025
11.02.2021 16.01.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 12.95% | |
---|---|---|
Novartis AG Registered Shares | 11.97% | |
Roche Holding AG | 11.85% | |
UBS Group AG | 5.60% | |
Zurich Insurance Group AG | 5.20% | |
ABB Ltd | 5.17% | |
Compagnie Financiere Richemont SA Class A | 4.89% | |
Holcim Ltd | 3.13% | |
Lonza Group Ltd | 2.55% | |
Swiss Re AG | 2.55% | |
Last data update | 31.12.2024 |
TER | 0.01% |
---|---|
TER date | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.00% |
SRRI ***
|
|
SRRI date *** | 31.12.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |
GMOs |